Sofinnova Investments, Inc. Aligos Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.08 - $12.2 $265,805 - $1.56 Million	-127,791 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.48 - $17.69 $39,594 - $61,012	3,449 Added 2.77%	127,791 $1.52 Million
Q3 2021 Nov 15, 2021	SELL	$14.57 - $17.72 $578,560 - $703,643	-39,709 Reduced 24.21%	124,342 $1.93 Million
Q2 2021 Aug 16, 2021	SELL	$20.3 - $33.6 $436,064 - $721,761	-21,481 Reduced 11.58%	164,051 $3.34 Million
Q1 2021 May 14, 2021	SELL	$19.1 - $34.94 $105,603 - $193,183	-5,529 Reduced 2.89%	185,532 $4.22 Million
Q4 2020 Feb 16, 2021	BUY	$13.2 - $32.74 $2.52 Million - $6.26 Million	191,061 New	191,061 $5.28 Million

253K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.